A new study suggests that patients who contract COVID-19 and completely recover from all symptoms do not show evidence of lasting damage to the lungs.
Aug 13, 2021
0
78
A very large team of researchers affiliated with institutions across China (and several from Washington University School of Medicine in the U.S.) has found recurrent alterations in prostate cancer in Chinese patients that ...
Cancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer.
Dec 19, 2019
0
598
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy ...
Jun 27, 2024
0
69
In addition to lowering your cholesterol, keeping your brain healthy and improving mental health, new research from the University of Georgia suggests omega-3 and omega-6 fatty acids may help ward off a variety of cancers.
Nov 4, 2024
0
57
(HealthDay)—If you use an oxygen concentrator and a pulse oximeter at home, proper use is crucial, the U.S. Food and Drug Administration says.
Nov 6, 2020
0
17
Repeats of DNA sequences, often referred to as "junk DNA" or "dark matter," that are found in chromosomes and could contribute to cancer or other diseases have been challenging to identify and characterize.
Mar 13, 2024
0
95
November is Lung Cancer Awareness month. Lung cancer is the most common cancer worldwide, with more than 2.1 million cases, according to the American Lung Association.
Nov 21, 2022
0
2
Adding a pre-ketone supplement—a component of a high-fat, low-carb ketogenic diet—to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers from the University ...
Apr 27, 2024
0
103
A team of researchers from Google Health, working with others from institutions across the U.S. and Canada has found that a Google AI system was able to outperform general pathologists when validating Gleason grading of prostate ...
